These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 32587778

  • 1. Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling.
    Zhang X, Zhang Y, Jia Y, Qin T, Zhang C, Li Y, Huang C, Liu Z, Wang J, Li K.
    Cancer Biol Med; 2020 May 15; 17(2):418-432. PubMed ID: 32587778
    [Abstract] [Full Text] [Related]

  • 2. Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor.
    Xie C, Wan X, Quan H, Zheng M, Fu L, Li Y, Lou L.
    Cancer Sci; 2018 Apr 15; 109(4):1207-1219. PubMed ID: 29446853
    [Abstract] [Full Text] [Related]

  • 3. Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
    Chen CY, Lin YJ, Wang CCN, Lan YH, Lan SJ, Sheu MJ.
    Biomed Pharmacother; 2019 Dec 15; 120():109491. PubMed ID: 31586903
    [Abstract] [Full Text] [Related]

  • 4. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.
    Wang G, Sun M, Jiang Y, Zhang T, Sun W, Wang H, Yin F, Wang Z, Sang W, Xu J, Mao M, Zuo D, Zhou Z, Wang C, Fu Z, Wang Z, Duan Z, Hua Y, Cai Z.
    Int J Cancer; 2019 Aug 15; 145(4):979-993. PubMed ID: 30719715
    [Abstract] [Full Text] [Related]

  • 5. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X, Wu L, Zhou X, Zhou N, Zhuang Q, Yang J, Dai J, Wang H, Chen S, Mao W.
    Microvasc Res; 2017 May 15; 111():25-31. PubMed ID: 28040437
    [Abstract] [Full Text] [Related]

  • 6. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G, Sun L, Pei Y, Wang D.
    Anticancer Agents Med Chem; 2018 May 15; 18(4):583-590. PubMed ID: 29065844
    [Abstract] [Full Text] [Related]

  • 7. Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation.
    Brossa A, Grange C, Mancuso L, Annaratone L, Satolli MA, Mazzone M, Camussi G, Bussolati B.
    Oncotarget; 2015 May 10; 6(13):11295-309. PubMed ID: 25948774
    [Abstract] [Full Text] [Related]

  • 8. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC, Lee CF, Huang WH, Chou TC.
    Biochem Pharmacol; 2013 May 01; 85(9):1278-87. PubMed ID: 23416116
    [Abstract] [Full Text] [Related]

  • 9. Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1.
    Lin B, Song X, Yang D, Bai D, Yao Y, Lu N.
    Gene; 2018 May 15; 654():77-86. PubMed ID: 29454091
    [Abstract] [Full Text] [Related]

  • 10. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Carcinogenesis; 2012 May 15; 33(5):1022-30. PubMed ID: 22436611
    [Abstract] [Full Text] [Related]

  • 11. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY, Xu H, Wu ZF, Chen C, Liu JY, Wu GN, Yao XQ, Liu FK, Li G, Shen L.
    Oncotarget; 2015 Dec 29; 6(42):44563-78. PubMed ID: 26575424
    [Abstract] [Full Text] [Related]

  • 12. Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy.
    Ichikawa K, Watanabe Miyano S, Minoshima Y, Matsui J, Funahashi Y.
    Sci Rep; 2020 Feb 19; 10(1):2939. PubMed ID: 32076044
    [Abstract] [Full Text] [Related]

  • 13. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y, Peng A, He S, Shao X, Nie C, Chen L.
    J Chemother; 2013 Oct 19; 25(5):298-308. PubMed ID: 24070138
    [Abstract] [Full Text] [Related]

  • 14. Curcuminoids Inhibit Angiogenic Behaviors of Human Umbilical Vein Endothelial Cells via Endoglin/Smad1 Signaling.
    Chou YF, Lan YH, Hsiao JH, Chen CY, Chou PY, Sheu MJ.
    Int J Mol Sci; 2022 Mar 31; 23(7):. PubMed ID: 35409247
    [Abstract] [Full Text] [Related]

  • 15. Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells.
    Palanisamy K, Nareshkumar RN, Sivagurunathan S, Raman R, Sulochana KN, Chidambaram S.
    Microvasc Res; 2019 Mar 31; 122():136-145. PubMed ID: 30144414
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity of anlotinib in malignant melanoma: modulation of angiogenesis and vasculogenic mimicry.
    Yang Q, Li Q, Fan H.
    Arch Dermatol Res; 2024 Jul 03; 316(7):447. PubMed ID: 38958761
    [Abstract] [Full Text] [Related]

  • 17. CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo.
    Dan H, Lei X, Huang X, Ma N, Xing Y, Shen Y.
    Microvasc Res; 2021 Jul 03; 136():104146. PubMed ID: 33610563
    [Abstract] [Full Text] [Related]

  • 18. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
    Yan XC, Cao J, Liang L, Wang L, Gao F, Yang ZY, Duan JL, Chang TF, Deng SM, Liu Y, Dou GR, Zhang J, Zheng QJ, Zhang P, Han H.
    J Am Heart Assoc; 2016 Feb 08; 5(2):. PubMed ID: 26857067
    [Abstract] [Full Text] [Related]

  • 19. Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.
    Yang J, Wang Q, Qiao C, Lin Z, Li X, Huang Y, Zhou T, Li Y, Shen B, Lv M, Feng J.
    Cell Mol Immunol; 2014 May 08; 11(3):285-93. PubMed ID: 24608894
    [Abstract] [Full Text] [Related]

  • 20. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
    Sadremomtaz A, Mansouri K, Alemzadeh G, Safa M, Rastaghi AE, Asghari SM.
    Biochim Biophys Acta Gen Subj; 2018 Dec 08; 1862(12):2688-2700. PubMed ID: 30251659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.